Market Place
Sourcing Support
Evox Therapeutics Taps Dr. Per Lundin as CEO
29 Apr 2024 //
CONTRACT PHARMA
Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer
29 Apr 2024 //
GLOBENEWSWIRE
Evox Therapeutics enters into agreement to advance AAV gene therapy
04 Aug 2023 //
GLOBENEWSWIRE
Evox Granted Key Exosome Purification Patent to Expand Patent Portfolio
17 May 2023 //
GLOBENEWSWIRE
Evox Tx Presents Progress Across its DeliverEX Exosome Therapeutics Platform
26 May 2022 //
GLOBENEWSWIRE
Evox Therapeutics to Present at the 2022 Jefferies Healthcare Conference
24 May 2022 //
GLOBENEWSWIRE
ISCGT Presentations Illustrate Evox`s Proprietary Exosome Engineering Platform
09 May 2022 //
GLOBENEWSWIRE
Evox Therapeutics Appoints Peter Jones as Vice President of CMC
14 Apr 2022 //
GLOBENEWSWIRE
Evox Therapeutics reels in $95M to propel exosome-based pipeline
18 Feb 2021 //
FIERCEBIOTECH
Evox raises £69.2m to advance exosome-based therapeutics pipeline
17 Feb 2021 //
PHARMATIMES
European Patent Office grants key exosome patent to Evox Therapeutics
25 Nov 2020 //
PHARMABIZ
Evox Therapeutics Expands Existing Exosome Patent Portfolio With Further Grant
15 Jul 2020 //
PRNEWSWIRE
Takeda-partnered Evox signs up to $1.2B pact with Lilly; New liquid biopsy
10 Jun 2020 //
ENDPTS
Evox Therapeutics Announces a Multi-target RNAi and Antisense Research Collab
08 Jun 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.